Quanex's (NYSE:NX) Q4 CY2025 Sales Beat Estimates

Building products company Quanex (NYSE:NX) announced better-than-expected revenue in Q4 CY2025, with sales up 2.3% year on year to $409.1 million. The company’s full-year revenue guidance of $1.86 billion at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP loss of $0.01 per share was 82.6% above analysts’ consensus estimates.

Is now the time to buy Quanex? Find out by accessing our full research report, it’s free.

George Wilson, Chairman, President and Chief Executive Officer, stated, “Our results for the first quarter tracked our expectations given the current macroeconomic backdrop. The combination of inflationary pressures, high interest rates, tariff uncertainty, housing affordability issues, and geopolitical tensions continued to weaken consumer confidence around the world, ultimately impacting demand for the products we manufacture. However, we continue to focus on identifying operational efficiencies and commercial synergies that we believe will benefit us when consumer confidence improves and demand rebounds.

Company Overview

Starting in the seamless tube industry, Quanex (NYSE:NX) manufactures building products like window, door, kitchen, and bath cabinet components.

Revenue Growth

A company’s long-term performance is an indicator of its overall quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. Thankfully, Quanex’s 15.8% annualized revenue growth over the last five years was incredible. Its growth beat the average industrials company and shows its offerings resonate with customers.

Long-term growth is the most important, but within industrials, a half-decade historical view may miss new industry trends or demand cycles. Quanex’s annualized revenue growth of 29.1% over the last two years is above its five-year trend, suggesting its demand was strong and recently accelerated.

We can dig further into the company’s revenue dynamics by analyzing its most important segments, Fenestration and Cabinet Components, which are 32.8% and 10.7% of revenue. Over the last two years, Quanex’s Fenestration revenue (window and door components, North America only) averaged 7.6% year-on-year declines while its Cabinet Components revenue (cabinet parts, North America only) was flat.

This quarter, Quanex reported modest year-on-year revenue growth of 2.3% but beat Wall Street’s estimates by 0.9%.

Looking ahead, sell-side analysts expect revenue to remain flat over the next 12 months, a deceleration versus the last two years. This projection doesn't excite us and implies its products and services will face some demand challenges.

ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.

AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.

Operating Margin

Operating margin is a key measure of profitability. Think of it as net income - the bottom line - excluding the impact of taxes and interest on debt, which are less connected to business fundamentals.

Quanex was profitable over the last five years but held back by its large cost base. Its average operating margin of 2.3% was weak for an industrials business. This result isn’t too surprising given its low gross margin as a starting point.

Analyzing the trend in its profitability, Quanex’s operating margin decreased by 17.6 percentage points over the last five years. This raises questions about the company’s expense base because its revenue growth should have given it leverage on its fixed costs, resulting in better economies of scale and profitability. Quanex’s performance was poor no matter how you look at it - it shows that costs were rising and it couldn’t pass them onto its customers.

In Q4, Quanex’s breakeven margin was 0.7%, up 2.4 percentage points year on year. The increase was encouraging, and because its operating margin rose more than its gross margin, we can infer it was more efficient with expenses such as marketing, R&D, and administrative overhead.

Earnings Per Share

Revenue trends explain a company’s historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth – for example, a company could inflate its sales through excessive spending on advertising and promotions.

Quanex’s EPS grew at an unimpressive 7.5% compounded annual growth rate over the last five years, lower than its 15.8% annualized revenue growth. This tells us the company became less profitable on a per-share basis as it expanded.

Diving into the nuances of Quanex’s earnings can give us a better understanding of its performance. As we mentioned earlier, Quanex’s operating margin expanded this quarter but declined by 17.6 percentage points over the last five years. Its share count also grew by 36.9%, meaning the company not only became less efficient with its operating expenses but also diluted its shareholders.

Like with revenue, we analyze EPS over a more recent period because it can provide insight into an emerging theme or development for the business.

For Quanex, its two-year annual EPS declines of 12.6% show it’s continued to underperform. These results were bad no matter how you slice the data.

In Q4, Quanex reported adjusted EPS of negative $0.01, down from $0.19 in the same quarter last year. Despite falling year on year, this print easily cleared analysts’ estimates. Over the next 12 months, Wall Street expects Quanex’s full-year EPS of $2.11 to grow 2.8%.

Key Takeaways from Quanex’s Q4 Results

It was good to see Quanex beat analysts’ EPS expectations this quarter. We were also glad its EBITDA outperformed Wall Street’s estimates. Zooming out, we think this was a good print with some key areas of upside. Investors were likely hoping for more, and shares traded down 1.1% to $18.61 immediately after reporting.

So should you invest in Quanex right now? We think that the latest quarter is only one piece of the longer-term business quality puzzle. Quality, when combined with valuation, can help determine if the stock is a buy. We cover that in our actionable full research report which you can read here (it’s free).